Retatrutide (Research-Grade) is a research-grade biosimilar monoclonal antibody targeting GLP-1 receptor. Format: Biosynthetic peptide.. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% as determined by HPLC. For research use only.
LY3437943 is an investigational triple-hormone receptor agonist developed by Eli Lilly and Company, targeting the receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. This unique mechanism aims to address metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH).
Product Name:
Retatrutide (Research-Grade)
SKU:
GXBS02476
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
GLP-1 receptor
Isotype:
Biosynthetic peptide.
Reactivity:
Human
Applications:
ELISA, Functional assay, Research in vivo
Synonyms:
LY3437943
Recommended Dilutions:
ELISA: 1:2000-1:20000
Purity:
>95% as determined by HPLC.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Purified by HPLC.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
